13F Filings History of TRV GP, LLC

Latest 13F report
Q2 2021 - 11 Aug 2021
Reported value
$0
Signature and title
Kevin Gillis - Chief Operating Officer
Location
Boston, MA
13F summary
Recent SEC Form 13F portfolio filings for TRV GP, LLC. Form 13F is generally due within 45 days after each calendar quarter ends. TRV GP, LLC reported 1 stock holding with total reported value $18,903,000 for Q2 2021.

Follow Filing Activity

Follow TRV GP, LLC and return when a new 13F portfolio filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q2 2021
Latest value
$18,903,000
Quarter delta
$0
Accepted
11 Aug 2021, 17:02
Quarter Holdings Reported value Bought Sold Net Top Holdings Form Type Filing Time
Q3 2021 0 $0 $0 -$18,903,000 -$18,903,000 13F-HR 05 Nov 2021, 16:47
Q2 2021 1 $18,903,000 $0 $0 $0 SESN 13F-HR 11 Aug 2021, 17:02
Q1 2021 1 $10,638,000 +$10,638,000 -$6,536,000 +$4,102,000 SESN 13F-HR 12 May 2021, 16:46
Q4 2020 1 $6,536,000 $0 $0 $0 EBIO 13F-HR 16 Feb 2021, 06:45
Q3 2020 1 $6,778,000 $0 -$42,113,000 -$42,113,000 EBIO 13F-HR 06 Nov 2020, 16:26
Q2 2020 2 $45,599,000 $0 -$3,986,489 -$3,986,489 CNST, EBIO 13F-HR 07 Aug 2020, 19:02
Q1 2020 2 $50,932,000 $0 -$47,144,776 -$47,144,776 CNST, EBIO 13F-HR 11 May 2020, 16:17
Q4 2019 2 $147,971,000 $0 -$38,461,000 -$38,461,000 CNST, EBIO 13F-HR 05 Feb 2020, 16:51
Q3 2019 3 $63,726,000 $0 -$4,567,975 -$4,567,975 RYTM, CNST, EBIO 13F-HR 04 Nov 2019, 16:19
Q2 2019 4 $88,363,000 $0 $0 $0 RYTM, CNST, EBIO, ZFGN 13F-HR 06 Aug 2019, 16:25
Q1 2019 4 $100,986,000 $0 -$27,409,905 -$27,409,905 RYTM, CNST, EBIO, ZFGN 13F-HR 03 May 2019, 16:15
Q4 2018 4 $100,224,000 $0 $0 $0 RYTM, CNST, EBIO, ZFGN 13F-HR 28 Jan 2019, 16:05
Q3 2018 4 $120,256,000 +$20,419,000 -$51,885,162 -$31,466,162 RYTM, CNST, EBIO, ZFGN 13F-HR 29 Oct 2018, 16:04
Q2 2018 4 $158,768,000 $0 $0 $0 RYTM, KALA, EBIO, ZFGN 13F-HR 07 Aug 2018, 16:05
Q1 2018 5 $112,072 $0 $0 $0 RYTM, KALA, EBIO, ZFGN 13F-HR 19 Apr 2018, 17:11
Q4 2017 5 $221,278,000 $0 $0 $0 RYTM, CTMX, KALA, EBIO, ZFGN 13F-HR 13 Feb 2018, 13:19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .